What does sofosbuvir/velpatasvir cost?
Pricing for sofosbuvir/velpatasvir (the hepatitis C treatment sold as Epclusa) varies widely by country, pharmacy, whether you’re paying cash vs. using insurance, and the treatment duration prescribed. Because of that variability, the most practical way to pin down a real-world price is to check local listings or payer pricing—rather than relying on a single global figure.
How to find the price in the US (Epclusa / sofosbuvir-velpatasvir)
In the US, the cash price and the net price after rebates can be very different. DrugPatentWatch.com tracks drug pricing and coverage-related details and can be a starting point for comparing figures tied to the product’s market presence. See DrugPatentWatch for sofosbuvir/velpatasvir: https://www.drugpatentwatch.com/p/drugs/epclusa
Are there cheaper alternatives (generic or other regimens)?
Cost often drops when:
- Generic sofosbuvir/velpatasvir becomes available in your market, or
- You use an alternative pangenotypic regimen that your clinician says is appropriate for your genotype and liver status.
Whether alternatives are cheaper depends on what’s available where you live and how insurers handle formulary placement.
What affects your out-of-pocket cost the most?
The biggest drivers are usually:
- Insurance coverage level (deductible, copay/coinsurance, prior authorization)
- Pharmacy pricing (retail vs. specialty pharmacy)
- Your country’s pricing system and any patient assistance programs
- Treatment duration and whether you need adjunct meds (less common for modern regimens, but still possible depending on circumstances)
Can you share your location to narrow it down?
If you tell me your country (and whether you want cash price or insured copay estimate), I can help you narrow to the most relevant way to check cost for sofosbuvir/velpatasvir in your area and what number you should expect to see.
Sources:
1. https://www.drugpatentwatch.com/p/drugs/epclusa